New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI ...

QRL-101, an oral small molecule being developed by QurAlis, was safe and reduced nerve-cell overactivity in ALS patients in an early study.

"To investigate the mechanisms driving local TDP-43 accumulation, we combined human ALS biopsies, transgenic mouse models, and neuron–muscle co-cultures grown in microfluidic chambers that allow us to ...

Changes in motor units closely reflect disease severity in people with spinal muscular atrophy (SMA), suggesting potential new biomarkers.

Researchers developed a laser-based artificial neuron that fully emulates the functions, dynamics and information processing of a biological graded neuron, which could lead to new breakthroughs in ...

A groundbreaking drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living with this devastating condition. Researchers at the University ...

Clonus causes involuntary, rhythmic muscle contractions when a muscle is stretched. It is often observed in conditions like multiple sclerosis, stroke, and cerebral palsy. Clonus can be diagnosed by ...